Pain Management Therapeutics Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC361

Increasing population of the world finds itself on high chronic pain epidemics; hence the necessity to handle chronic pain as a publically declared health issue by scholars and public health practitioners is witnessing significant strength. Presently, around 20% of the world’s total population suffer from chronic pain. Various factors such as increased number of surgeries, changing lifestyles, rising prevalence of chronic diseases and rising geriatric population continue to add approximately 10% new patients to the aforementioned numbers every consecutive year. Pain management also called as algiatry is a branch of medicinal studies which utilizes an interdisciplinary approach to facilitate and improve overall quality of life. Pain is an ultimate result of tissue damage or trauma and the intensity of pain varies from person to person. Pain can be bifurcated on the basis of its duration and occurrence and coupled with the affected body part. The very first stage of treatment of pain is termed as pain killer drugs or pharmaceutical therapeutics. Various other pain management procedures include pain managing devices, physiotherapy and chiropractor therapy. Pain is usually defined as a type of unpleasant physical sensation generally caused by any injury or illness. The pain management field is categorized on large scale into medicinal and physical treatment. Several cancer therapies result in pain and trauma injuries and have fueled the demand for efficient pain management services. Increasing focus of pain management service providers on commercialization of pain management drugs with minimal side effects, ambulatory pain management solutions and reformed reimbursement policies are some of the key factors shaping the growth prospect of pain management therapeutics market, globally.

Increased focus on palliative care treatment, reimbursement for pain management treatment, supportive regulations and growing healthcare expenditures coupled with increasing prevalence of cancer patients are some of the key factors surging the growth of overall global pain management therapeutics market. Moreover, strong prevalence of chronic pain ailments, efficient and effective treatment options as well as favorable regulatory framework are some of the major drivers propelling the growth of global pain management therapeutics market. Also, consistent focus of medical device manufacturers to come up with cost effective products and increase in the number of trauma cases along with accidental injuries is fuelling the growth of global pain management therapeutics market. However, limited availability, lack of awareness for advanced pain medication, chronic side effects and higher probabilities of addiction from pain medicines is expected to impede the growth of global pain management therapeutics market.

The global pain management therapeutics market can be segmented on the basis of devices, disease condition, class of drug, end-user and geography. On the basis of devices, the global pain management therapeutics market can be segmented into analgesic infusion pumps, spinal cord stimulators, neuro-stimulation devices, electrical stimulation devices and radiofrequency ablation devices. On the basis of disease condition, the global pain management therapeutics market can be segmented into trauma, injury, cancer, anesthesia, surgical pain, terminal conditions, neuropathic pain and others. On the basis of class of drug, the global pain management therapeutics market can be segmented into narcotics pain killer, non-narcotics analgesics, muscle relaxants, anti-anxiety drugs and others. On the basis of end-user, the global pain management therapeutics market can be segmented into surgical centers, clinics and hospitals. In terms of geography, the global pain management therapeutics market can be divided into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa.

The global pain management therapeutics market is anticipated to witness a soaring competition in the near future owing to the entry of a large number of local and generic drug manufacturers. Key players operating in the global pain management therapeutics market include Endo Health Solutions, Pfizer, Inc., Eli Lilly & Co., AstraZeneca PLC., Purdue Pharma L.P. and Johnson & Johnson among others.

Market Segmentation

Market by Device Type

·         Analgesic infusion pumps

·         Spinal cord stimulators

·         Neuro-stimulation devices

·         Electrical stimulation devices

·         Radiofrequency ablation devices

Market by Disease Condition

·         Trauma

·         Injury

·         Cancer

·         Anesthesia

·         Surgical pain

·         Terminal conditions

·         Neuropathic pain

·         Others

Market by Class of Drug

·         Narcotics pain killer

·         Non-narcotics analgesics

·         Muscle relaxants

·         Anti-anxiety drugs

·         Others

Market by End-user

·         Surgical centers

·         Clinics

·         Hospitals

Market by Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Philippines

o   Rest of Asia-Pacific

·         Latin America

o    Brazil

o   Chile

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Digital Pill Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Introduction Digital pill is a pharmaceutical dosage form and it is consists of ingestible sensor inside of a pill. A small, swallowable sensor named AbilifyMyCite that tracks path when the patient swallows their medicines. The tablet is precisely targeted for ...

Fish Collagen Hydrolysate Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Introduction Fish Collagen Hydrolyzed is mass-produced from collagen and it is the primary protein originates from bones and skin. Animal collagen is naturally extracted from porcine orbovine skin whereas fish collagen is made from the skin of ocean ordeep wate...

Cart Summary

Special Pricing & Discounts